Navigation Links
Lotus Pharmaceuticals Provides Inner Mongolia Land Price Guidance from Cha You Qian Qi Government
Date:1/27/2011

BEIJING, Jan. 27, 2011 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUSD) ("Lotus" or the "Company"), a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China ("PRC"), announced today that in response to recent investor interest, the Company has obtained land price guidance from the Cha You Qian Qi local government and wishes to provide additional details regarding its 2008 purchase of land assets in Inner Mongolia.

The land purchase was entered into by Liang Fang, the Company's subsidiary, with both Cha You Qian Qi ("Cha You") local government and Mengxin Vegetable Product Company ("Mengxin"), a private company and the prior owner of the land use rights. With the permission of Cha You local government, Liang Fang was granted the land use right of the 1,000 mu (approximately 666,700 square meters) from Mengxin, and the payment of RMB 223.66 million ($32.7 million) was paid to Mengxin.

Officials from the Cha You Qian Qi Land Reserve and Trade Center, a subsidiary of Cha You Qian Qi Land and Resource Bureau, have confirmed that the land has been designated for multi-purpose use and has presented the Company with price guidance for the land and surrounding area. The guidance indicates that as multiple-use land, the market value of the property is approximately RMB 400,000-600,000 per mu (RMB 600-900 per square meter). Property values in the area surrounding the land vary by about RMB 100,000 per mu (RMB 150 per square meter) from this range.

Dr. Zhongyi Liu, Chairman and CEO of Lotus, stated, "We spent approximately RMB 270 per square meter for this land tract in 2008. Since the purchase, we have made additional investments of approximately RMB 126 per square meter on road construction, water supply, electricity, and sewage, as well as relocation compensation, bringing the total cost of the land to approximately RMB 396 per square meter. Given current local market conditions, we believe we can sell the land at a price higher than our cost."

About Lotus Pharmaceuticals, Inc. Lotus Pharmaceuticals, Inc. is a fast-growing, profitable developer and producer of drugs and a licensed national seller of pharmaceutical items in the People's Republic of China (PRC). Lotus operates its business through its two controlled entities: Liang Fang Pharmaceutical, Ltd. and En Ze Jia Shi Pharmaceutical, Ltd. Lotus' current drug development is focused on the treatment of cerebro-cardiovascular diseases, asthma and diabetes. Liang Fang sells drugs directly and indirectly through its national sales channels to hospitals, clinics and drugs stores in 30 provinces of the PRC.

Information Regarding Forward-Looking StatementsExcept for historical information contained herein, the statements in this press release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause our actual results in future periods to differ materially from forecasted results. These risks and uncertainties include, among other things, product demand, market competition, and risks inherent in our operations. These and other risks are described in our filings with the U.S. Securities and Exchange Commission.Contacts:At the Company:Xing Shen, Ph.D.VP of Corporate DevelopmentLotus Pharmaceuticals, Inc.Ph: 415-690-7688Email: shen@lotuspharma.com Web: http://www.lotuspharma.comInvestor Relations:Dave Gentry, PresidentRedChip Companies, Inc.Tel: +1-800-733-2447, Ext. 104Email: info@redchip.comWeb: http://www.redchip.com
'/>"/>

SOURCE Lotus Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Lotus Pharmaceuticals Announces Approval of Reverse Stock Split
2. Lotus Pharmaceuticals Announces Change of Directors
3. Lotus Pharmaceuticals Announces Update on Land in Inner Mongolia
4. Lotus Pharmaceuticals Announces Conference Call to Discuss Third Quarter 2010 Financial Results
5. Lotus Pharmaceuticals Preparing to Apply for National Exchange Listing
6. Lotus Pharmaceuticals Retains Sichenzia Ross Friedman Ference LLP as General Legal Counsel
7. Lotus Pharmaceuticals Announces Two Senior Management Appointments
8. Lotus Pharmaceuticals Announces Engagement of RedChip Companies to Lead Public and Investor Relations Efforts
9. Lotus Pharmaceuticals Enter R-Bambuterol(R) Clinical Trial I
10. Lotus Pharmaceuticals Reports Strong Second Quarter 2010 Financial Results
11. Lotus Completed R-Bambuterols Pilot Scale Production for Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)...  Resolve Therapeutics, LLC, a clinical stage biopharmaceutical ... treatment of lupus and Sjogrens syndrome, today announced ... study in patients with systemic lupus erythematosus (SLE) ... --> --> Data from a ... of RSLV-132 in 32 subjects with SLE demonstrate ...
(Date:2/10/2016)...  Rich Pharmaceuticals, Inc. (OTC Markets: RCHA) ("Rich Pharmaceuticals" ... of its issued and outstanding shares of common stock ... 11, 2016. The Company,s common stock will trade on ... temporary ticker symbol "RCHAD". After 20 trading days, the ... (RCHA).  --> --> ...
(Date:2/10/2016)... , Feb. 10, 2016  The ... Nursing received an in-kind gift from ... a VeinViewer® Vision vein finder for the ... help students as they learn how to ... technology with traditional technique. ...
Breaking Medicine Technology:
(Date:2/10/2016)... , ... February 10, 2016 , ... ... effectively measure change in their patients. Research shows that the Goal Attainment Scale ... help therapists overcome this challenge and learn more about the Goal Attainment Scale, ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... will attend the Ohio Safety Congress and Expo event March 9-11, 2016. Hosted ... Greater Columbus Convention Center. , As the longest running and largest worker's ...
(Date:2/10/2016)... ... February 10, 2016 , ... Everseat has ... readily available to physicians. The integration will enable Allscripts users to post ... via Everseat’s free mobile app. , The partnership gives Everseat substantial added power ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... UNF Drive, Jacksonville, FL 32224, February 26th: Amateur & Professional Divisions - ... - Time: 7:00pm – 10:00pm | Ticket Prices $30, Social Media: ...
(Date:2/10/2016)... ... February 10, 2016 , ... Workrite Ergonomics, who is celebrating their ... from humble beginnings to being an internationally recognized leader in their industry. , "We ... said Charlie Lawrence, President of Workrite. “Workrite recognized the importance of good ergonomics ...
Breaking Medicine News(10 mins):